arrow
G

Gemma L. Kelly

the walter and eliza hall institute of medical research
H指数:36
被引数:8,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo

高密度CRISPR激活平台用于体外和体内绘制癌症依赖性和耐药通路

2026-09-180
OA
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

全基因组活体内CRISPR筛选鉴定GATOR1复合物为Myc驱动的淋巴瘤的肿瘤抑制因子

2025-08-210
OAAI
Mouse models to investigate in situ cell fate decisions induced by p53
2024-08-190
OAAI
Genome-scale clustered regularly interspaced short palindromic repeats screen identifies nucleotide metabolism as an actionable therapeutic vulnerability in diffuse large B-cell lymphoma
2024-06-061
OAAI
Cancer Hallmarks: Piecing the Puzzle Together
2024-04-042
OA
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
2023-10-2422
OAAI
Apoptotic cell death in disease-Current understanding of the NCCD 2023

疾病中的凋亡细胞死亡-对NCCD 2023的当前理解

2023-04-26143
OAAI
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Feb,10.1038/s41418-023-01122-3, 2023)
2023-02-240
OAAI
Generation of a CRISPR activationmouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (vol 13, 4739, 2022)
2022-08-250
OAAI
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
2022-08-1214
OAAI